Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Silver

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
JAMA|April 27, 1994
Tubal ligation, hysterectomy, and risk of ovarian cancerA L Silver
The Mount Sinai Journal of Medicine, New York|November 1, 1992
Kurt W. Deuschle and community medicine: clinical care, statistical compassion, community empowermentA L Silver, D N Rose
Annals of Internal Medicine|August 1, 1989
Life expectancies: population or person?A L Silver, D N Rose
Clinical Performance and Quality Health Care|December 9, 1995
Inpatient treatment patterns of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in New York State Medicare patientsA L Silver, A Eichorn, G P Pickett
JAMA|November 21, 1986
The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactorsD N Rose, C B Schechter, A L Silver
Archives of Internal Medicine|September 1, 1991
Isoniazid prophylaxis for young adultsD N Rose, C B Schechted, A L Silver
The Mount Sinai Journal of Medicine, New York|April 1, 1985
Tuberculosis chemoprophylaxis for diabetics: are the benefits of isoniazid worth the risk?D N Rose, A L Silver, C B Schechter
JAMA|August 21, 1987
Discounting, isoniazid, and tuberculosisD N Rose, C B Schechter, A L Silver
Journal of Neuroscience Research|April 5, 2001
NID67, a small putative membrane protein, is preferentially induced by NGF in PC12 pheochromocytoma cellsL Vician, A L Silver, R Farias-Eisner, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1995
Surgical antibiotic prophylaxis and Clostridium difficile toxin positivityD Kreisel, T G Savel, A L Silver, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
JAMA|April 27, 1994
Tubal ligation, hysterectomy, and risk of ovarian cancerA L Silver
The Mount Sinai Journal of Medicine, New York|November 1, 1992
Kurt W. Deuschle and community medicine: clinical care, statistical compassion, community empowermentA L Silver, D N Rose
Annals of Internal Medicine|August 1, 1989
Life expectancies: population or person?A L Silver, D N Rose
Clinical Performance and Quality Health Care|December 9, 1995
Inpatient treatment patterns of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in New York State Medicare patientsA L Silver, A Eichorn, G P Pickett
JAMA|November 21, 1986
The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactorsD N Rose, C B Schechter, A L Silver
Archives of Internal Medicine|September 1, 1991
Isoniazid prophylaxis for young adultsD N Rose, C B Schechted, A L Silver
The Mount Sinai Journal of Medicine, New York|April 1, 1985
Tuberculosis chemoprophylaxis for diabetics: are the benefits of isoniazid worth the risk?D N Rose, A L Silver, C B Schechter
JAMA|August 21, 1987
Discounting, isoniazid, and tuberculosisD N Rose, C B Schechter, A L Silver
Journal of Neuroscience Research|April 5, 2001
NID67, a small putative membrane protein, is preferentially induced by NGF in PC12 pheochromocytoma cellsL Vician, A L Silver, R Farias-Eisner, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1995
Surgical antibiotic prophylaxis and Clostridium difficile toxin positivityD Kreisel, T G Savel, A L Silver, et al.
Pageof 3